What Is ZBH Fair Value?
Zimmer Biomet (ZBH) fair value estimate using multiple valuation models, updated daily.
As of July 16, 2026, Zimmer Biomet (ZBH) has a composite fair value estimate of $104.04 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $90.14, suggesting the stock is undervalued by 15.4%.
Data as of July 16, 2026 (today)
Composite Fair Value
Undervalued4 of 4 models$104.04
vs. current price of $90.14(+15.4%)
How Is ZBH Fair Value Calculated?
Four independent models estimate what ZBH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
ZBH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$125.68
+39.4%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$20.95
-76.8%Overvalued
Inputs used
ZBH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$111.80
+24.0%Undervalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$84.78
-5.9%Fair Value
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $90.14 is 39.4% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.09B | $1.03B |
| Year 2 | $1.14B | $1.02B |
| Year 3 | $1.20B | $1.00B |
| Year 4 | $1.25B | $989.7M |
| Year 5 | $1.31B | $976.6M |
| Year 6 | $1.37B | $963.6M |
| Year 7 | $1.44B | $950.8M |
| Year 8 | $1.51B | $938.1M |
| Year 9 | $1.58B | $925.7M |
| Year 10 | $1.65B | $913.4M |
| Terminal Value | $47.01B | $26.01B |
What Are ZBH's Key Financial Metrics?
Earnings & Growth
Current Price
$90.14
EPS (TTM)
$3.82
Forward P/E
10.0
Profit Margin
9.1%
Cash & Balance Sheet
Free Cash Flow
1B
EBITDA
2.6B
Book Value
$65.53
Total Debt
7.6B
What Do Analysts Say About ZBH?
Low
$83.00
Average
$98.05
High
$130.00
Upside
+8.8%
ZBH Fair Value FAQ
What is the fair value of ZBH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), ZBH's estimated fair value is $104.04. The stock is currently trading at $90.14, which makes it undervalued by our analysis.
How is ZBH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is ZBH overvalued or undervalued?
Based on our analysis, ZBH is undervalued. The current price of $90.14 is 15.4% below our estimated fair value of $104.04.
What do Wall Street analysts say about ZBH?
21 analysts cover Zimmer Biomet with a consensus rating of "Hold." The average price target is $98.05, ranging from $83.00 to $130.00. This implies 8.8% upside from the current price.